Literature DB >> 10636121

Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?

R M Van den Berg-Vos1, L H Van den Berg, H Franssen, M Vermeulen, T D Witkamp, G H Jansen, H W van Es, H Kerkhoff, J H Wokke.   

Abstract

BACKGROUND: Several patients have been reported with an asymmetric sensory or sensorimotor demyelinating neuropathy not fulfilling the diagnostic criteria for chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy.
OBJECTIVE: To present the clinical, electrophysiologic, radiologic, and pathologic features of six patients with an asymmetric sensory or sensorimotor demyelinating neuropathy.
RESULTS: All six patients were initially affected in only one limb; in four patients the neuropathy progressed to other limbs in an asymmetric fashion during several years. On electrophysiologic examination, evidence of multifocal demyelination and conduction block in motor and sensory nerves was found in all patients. MRI of the brachial plexus revealed swollen nerves and an increased signal intensity on T2-weighted imaging in four patients. A biopsy sample taken from the brachial plexus of one patient revealed evidence of inflammation. All patients showed a beneficial response to IV immunoglobulin treatment. Thirty-four similar patients have been reported previously, many of whom were initially diagnosed as having various other (nontreatable) diseases.
CONCLUSIONS: The authors propose calling this neuropathy "multifocal inflammatory demyelinating neuropathy" and considering it as a distinct clinical entity to facilitate early diagnosis of this treatable disorder.

Entities:  

Mesh:

Year:  2000        PMID: 10636121     DOI: 10.1212/wnl.54.1.26

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

Review 2.  [Immune-mediated neuropathies].

Authors:  G Stoll; K Reiners
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

Review 3.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

4.  Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin.

Authors:  M Odaka; M Tatsumoto; K Susuki; K Hirata; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

5.  A case of Lewis-Sumner syndrome showing dramatic improvement after plasma exchange.

Authors:  Young-Eun Park; Ji-Won Yook; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2010-06-16       Impact factor: 2.153

Review 6.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

Review 7.  Magnetic resonance imaging of the peripheral nervous system.

Authors:  Guido Stoll; Martin Bendszus; Jose Perez; Mirko Pham
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

Review 8.  Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.

Authors:  T Umapathi; Richard A C Hughes; Eduardo Nobile-Orazio; Jean-Marc Léger
Journal:  Cochrane Database Syst Rev       Date:  2015-03-04

9.  Asymmetric Acquired Demyelinating Polyneuropathies: MMN and MADSAM.

Authors:  Jonathan S. Katz; David S. Saperstein
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.972

10.  Brachial plexus magnetic resonance imaging differentiates between inflammatory neuropathies and does not predict disease course.

Authors:  Bas A Jongbloed; Jeroen W Bos; Dirk Rutgers; Willem Ludo van der Pol; Leonard H van den Berg
Journal:  Brain Behav       Date:  2017-04-04       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.